The impact of migrations on the health services for rare diseases in Europe: The example of haemoglobin disorders

The Scientific World Journal

Volumn 2013, Issue , 2013, Pages

  Angastiniotis, Michalis ^a,b   Vives Corrons, Joan Lluis ^b,c   Soteriades, Elpidoforos S ^a,d,e   Eleftheriou, Androulla ^a,b  

^a Thalassaemia International Federation (TIF)   (Cyprus)

^b European Network for Rare and Congenital Anaemias (ENERCA)   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d Cyprus Institute of Biomedical Sciences CIBS   (Cyprus)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN C; HEMOGLOBIN E; HEMOGLOBIN S;

ARTICLE; AUSTRIA; AWARENESS; BELGIUM; BETA THALASSEMIA; CYPRUS; DENMARK; FRANCE; GERMANY; GREECE; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH PROGRAM; HEALTH SERVICES RESEARCH; HEALTH SURVEY; HETEROZYGOTE; HUMAN; IMMIGRANT; ITALY; MAJOR CLINICAL STUDY; MIGRATION; NETHERLANDS; REGISTER; SICKLE CELL ANEMIA; SPAIN; SWEDEN; UNITED KINGDOM; ADOLESCENT; ADULT; AGED; CHILD; EUROPE; FEMALE; HEMOGLOBINOPATHY; MALE; MIDDLE AGED; PRESCHOOL CHILD; PREVALENCE; RARE DISEASE; RISK FACTOR; STATISTICS; UTILIZATION REVIEW;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DELIVERY OF HEALTH CARE; EUROPE; FEMALE; HEMOGLOBINOPATHIES; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RARE DISEASES; RISK FACTORS; TRANSIENTS AND MIGRANTS; UTILIZATION REVIEW; YOUNG ADULT;

EID: 84876552799     PISSN: 1537744X     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2013/727905     Document Type: Article

References (31)

1. Angastiniotis M., Modell B., Global epidemiology of hemoglobin disorders. Annals of the New York Academy of Sciences 1998 850 251 269 2-s2.0-0031855380 10.1111/j.1749-6632.1998.tb10482.x (Pubitemid 28369766)
2. Modell B., Darlison M., Global epidemiology of haemoglobin disorders and derived service indicators. Bulletin of the World Health Organization 2008 86 6 480 487 2-s2.0-44949128064 10.2471/BLT.06.036673 (Pubitemid 351821761)
3. Modell B., Darlison M., Birgens H., Cario H., Faustino P., Giordano P. C., Gulbis B., Hopmeier P., Lena-Russo D., Romao L., Theodorsson E., Epidemiology of haemoglobin disorders in Europe: an overview. Scandinavian Journal of Clinical and Laboratory Investigation 2007 67 1 39 69 2-s2.0-33846957753 10.1080/00365510601046557
4. Enerca White Book. in print
5. Cappellini M. D., Cohen A., Elefhteriou A., Piga A., Porter J., Taher A., Guidelines for the Clinical Management of Thalassaemia 2008 2nd Nicosia, Cyprus Thalassaemia International Federation
6. Weatherall D. J., Thalassemia as a global health problem: recent progress toward its control in the developing countries. Annals of the New York Academy of Sciences 2010 1202 17 23 2-s2.0-77955899256 10.1111/j.1749-6632.2010.05546.x
7. Angastiniotis M., Kyriakidou S., Hadjiminas M., How thalassaemia was controlled in Cyprus. World Health Forum 1986 7 3 291 297 2-s2.0-0022833871
8. Bianco I., Graziani B., Lerone M., Prevention of thalassaemia major in Latium (Italy). The Lancet 1985 2 8460 888 889 2-s2.0-0022408942 (Pubitemid 16242686)
9. Petrou M., The UK control programme for the haemoglobin disorders. Fetal and Maternal Medicine Review 1994 6 4 191 201 2-s2.0-0028596524
10. Cao A., Galanello R., Rosatelli M. C., Prenatal diagnosis and screening of the haemoglobinopathies. Bailliere's Clinical Haematology 1998 11 1 215 238 2-s2.0-0032415999 10.1016/S0950-3536(98)80076-0 (Pubitemid 29039024)
11. Piel F. B., Patil A. P., Howes R. E., Nyangiri O. A., Gething P. W., Dewi M., Temperley W. H., Williams T. N., Weatherall D. J., Hay S. I., Global epidemiology of sickle haemoglobin in neonates: a contemporary geoststistical model-based map and population estimates. The Lancet 2012 381 9861 142 151 10.1016/S0140-6736(12)61229-X
12. Eurostat population database. http://epp.eurostat.ec.europa.eu/portal/ page/portal/population/data/database
13. Modell's Haemoglobinopathologist's Almanac. http://www.modell-almanac. net/
14. Thuret I., Pondarré C., Loundou A., Steschenko D., Girot R., Bachir D., Rose C., Barlogis V., Donadieu J., de Montalembert M., Hagege I., Pegourie B., Berger C., Micheau M., Bernaudin F., Leblanc T., Lutz L., Galactéros F., Siméoni M. C., Badens C., Complications and treatment of patients with β -thalassemia in France: results of the National Registry. Haematologica 2010 95 5 724 729 10.3324/haematol.2009.018051
15. Voskaridou E., Ladis V., Kattamis A., Hassapopoulou E., Economou M., Kourakli A., Maragkos K., Kontogianni K., Lafioniatis S., Vrettou E., Koutsouka F., Papadakis A., Mihos A., Eftihiadis E., Farmaki K., Papageorgiou O., Tapaki G., Maili P., Theohari M., Drosou M., Kartasis Z., Aggelaki M., Basileiadi A., Adamopoulos I., Lafiatis I., Galanopoulos A., Xanthopoulidis G., Dimitriadou E., Mprimi A., Stamatopoulou M., Haile E. D., Tsironi M., Anastasiadis A., Kalmanti M., Papadopoulou M., Panori E., Dimoxenou P., Tsirka A., Georgakopoulos D., Drandrakis P., Dionisopoulou D., Ntalamaga A., Davros I., Karagiorga M., A national registry of haemoglobinopathies in Greece: deducted demographics, trends in mortality and affected births. Annals of Hematology 2012 91 9 1451 1458
16. Telfer P., Coen P. G., Christou S., Hadjigavriel M., Kolnakou A., Pangalou E., Pavlides N., Psiloines M., Simamonian K., Skordos G., Sitarou M., Angastiniotis M., Survival of medically treated thalassemia patients in Cyprus. Trends and risk factors over the period 1980-2004. Haematologica 2006 91 9 1187 1192 2-s2.0-33748807736 (Pubitemid 44408428)
17. Ceci A., Mangiarini L., Felisi M., Bartoloni F., Ciancio A., Capra M., D'Ascola D., Cianculli P., Filosa A., The management of iron chelation therapy: preliminary data from a national registry of thalassaemic patients. Anemia 2011 2011 7 435683 10.1155/2011/435683
18. Modell B., Khan M., Darlison M., King A., Layton M., Old J., Petrou M., Varnavides L., A national register for surveillance of inherited disorders: β thalassaemia in the United Kingdom. Bulletin of the World Health Organization 2001 79 11 1006 1013 2-s2.0-0035171882 (Pubitemid 33078669)
19. Modell B., Khan M., Darlison M., Westwood M. A., Ingram D., Pennell D. J., Improved survival of thalassaemia major in the UK and relation to T 2 cardiovascular magnetic resonance. Journal of Cardiovascular Magnetic Resonance 2008 10 1, article 42 2-s2.0-57349095277 10.1186/1532-429X-10-42
20. Weinreich S. S., De Lange-De Klerk E. S., Rijmen F., Cornel M. C., De Kinderen M., Plass A. M. C., Raising awareness of carrier testing for hereditary haemoglobinopathies in high-risk ethnic groups in the Netherlands: a pilot study among the general public and primary care providers. BMC Public Health 2009 9, article 338 2-s2.0-70350361982 10.1186/1471-2458-9-338
21. Gill P. S., Modell B., Thalassaemia in Britain: a tale of two communities. British Medical Journal 1998 317 7161 761 762 2-s2.0-0032547518 (Pubitemid 28427222)
22. Modell B., Harris R., Lane B., Khan M., Darlison M., Petrou M., John O., Layton M., Varnavides L., Informed choice in genetic screening for thalassaemia during pregnancy: audit from a national confidential inquiry. British Medical Journal 2000 320 7231 337 341 2-s2.0-0034606928 (Pubitemid 30083182)
23. Ahmed S., Bryant L. D., Tirzo Z., Shickle D., Interpretations of informed choice in antenatal screening: a cross-cultural, Q-methodology study. Social Science & Medicine 2012 74 7 997 1004 10.1016/j.socscimed.2011.12.021
24. Amato A., Grisanti P., Lerone M., Ponzini D., Di Biagio P., Cappabianca M. P., Giordano P. C., Prevention strategies for severe hemoglobinopathies in endemic and nonendemic immigration countries: the Latium example. Prenatal Diagnosis 2009 29 12 1171 1174 10.1002/pd.2382
25. Dyson S. M., 'Race', ethnicity and haemoglobin disorders. Social Science and Medicine 1998 47 1 121 131 2-s2.0-0031832424 10.1016/S0277-9536(98)00023-9 (Pubitemid 28297277)
26. Giordano P. C., Dihal A. A., Harteveld C. L., Estimating the attitude of immigrants toward primary prevention of the hemoglobinopathies. Prenatal Diagnosis 2005 25 10 885 893 2-s2.0-27144517469 10.1002/pd.1206 (Pubitemid 41508870)
27. Modell B., Petrou M., Layton M., Varnavides L., Slater C., Ward R. H. T., Rodeck C., Nicolaides K., Gibbons S., Fitches A., Old J., Audit of prenatal diagnosis for haemoglobin disorders in the United Kingdom: the first 20 years. British Medical Journal 1997 315 7111 779 784 2-s2.0-0030930538 (Pubitemid 27405944)
28. Forni G. L., Puntoni M., Boeri E., Terenzani L., Balocco M., The influence of treatment in specialized centers on survival of patients with thalassemia major. American Journal of Hematology 2009 84 5 317 318 2-s2.0-65649119698 10.1002/ajh.21398
29. WHO Resolution EB118. R1
30. WHA.R20
31. Dyson S. M., Atkin K., Sickle cell and thalassaemia: global public health issues come of age. Ethnicity and Health 2011 16 4-5 299 311 2-s2.0-79961139740 10.1080/13557858.2011.588397